| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SKA_B
|
263.40 | 103.9B | 3.92 | 1.77 | 2.97 | 9.1% | 8.7% | 82 | 61 | 540.24 | +78.8% | 82 | 0.26 |
|
BRAV
|
132.60 | 27.1B | 4.83 | 2.96 | 4.23 | 10.8% | 9.1% | 72 | 64 | 233.26 | +56.9% | 68 | 0.44 |
|
INSTAL
|
36.12 | 9.7B | 5.97 | 2.78 | 3.31 | 7.9% | 8.2% | 72 | 64 | 62.25 | +54.3% | 61 | 1.02 |
|
NYAB
|
6.88 | 4.9B | 46.62 | 23.52 | 32.66 | 147.0% | 10.9% | 41 | 52 | 2.02 | -52.9% | 96 | 0.06 |
|
BWEO
|
56.90 | 14.7B | 100.00 | 14.93 | 35.03 | 11.4% | 9.6% | 31 | 23 | 14.22 | -56.3% | 69 | 1.07 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.